Johnson & Johnson agreed on 28 July 2026 to a $5.5 billion settlement to resolve approximately 69,000 US lawsuits consolidated in federal court in New Jersey, alleging that its talc-based baby powder and related products caused ovarian cancer [Brief - 2026-07-29]. The settlement covers cases related to talc-based baby powder and associated products. This development was the primary subject of briefings published on both 28 and 29 July 2026, and was referenced again in a subsequent update on 8 August 2026 [Brief - 2026-08-08].
Johnson & Johnson's trailing twelve-month revenue stood at $97.93 billion as of 28 June 2026, representing year-over-year growth of 6.60% [SEC 10-Q - JNJ - 2026-06-28]. Gross margin was recorded at 67.91%, operating margin at 27.37%, and net margin at 21.48%, with net income of $21.04 billion over the same period. EPS declined 0.87% year-over-year. The company held $20.42 billion in cash against total debt of $49.04 billion. The P/E ratio stood at 30.24 [SEC 10-Q - JNJ - 2026-06-28].
Insider activity over the past 30 days comprised 11 transactions with a net selling direction, totalling approximately $54.6 million in net disposals [SEC Form 4 - JNJ - 2026-08]. On the institutional side, five notable firms opened new positions in JNJ during the most recent reporting period: Citadel (Ken Griffin), AQR Capital (Cliff Asness), Millennium (Izzy Englander), Bridgewater (Ray Dalio), and Soros Fund Management (George Soros) each initiated new holdings [SEC 13F - Citadel - Q2 2026; SEC 13F - AQR Capital - Q2 2026; SEC 13F - Millennium - Q2 2026; SEC 13F - Bridgewater - Q2 2026; SEC 13F - Soros Fund Mgmt - Q2 2026].
The prevailing macro backdrop features a 10-year US Treasury yield of 4.63% and a 2-year yield of 4.15%, producing a normal yield curve spread of 48 basis points [FRED DGS10; FRED DGS2]. This report was generated in response to material institutional position changes, specifically the simultaneous opening of new JNJ positions by five significant asset managers as disclosed in the most recent round of 13F filings.